Pfizer Inc (PFE)

$27.37 0.00 (N/A)
Market Cap 155.62B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.54
Forward PE 9.29
Profit Margin 12.42%
Debt to Equity Ratio 0.66
Volume 24,779,510
Avg Vol 49,559,352
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 61%
Beta 0.47
Analysts Sell
Price Target $28.64

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
DragonAlgo
DragonAlgo Feb. 19 at 2:22 AM
🐉 $PFE PUT — DragonAlgo® Signal Contract: PFE PUT Expiry: 2026-02-20 | Strike: $27.00 | Type: PUT Option Plan (premium): Entry: $0.10 Stop: $0.07 TP1: $0.12 TP2: $0.16 TP3: $0.23 🔗 https://dragonalgo.com
0 · Reply
Charterdi3
Charterdi3 Feb. 19 at 12:53 AM
$HR $UNH $PFE End of week watch !!!!
0 · Reply
Outcomes
Outcomes Feb. 18 at 11:23 PM
$MRNA $PFE ….mRNA bad
0 · Reply
F_I_R_E_
F_I_R_E_ Feb. 18 at 9:25 PM
$WMT stop crying about the p/e. Plenty of stocks with p/e under 30 ex: $T $PFE $LYFT , but look at their performance 🎭
2 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 18 at 9:01 PM
$PFE shitter lol
0 · Reply
himsssss
himsssss Feb. 18 at 8:49 PM
$VKTX $PFE $NVO$ABBV The management team added each other on myspace this time. Trust me bros.
0 · Reply
jogabonito84
jogabonito84 Feb. 18 at 8:13 PM
$IBRX $ONC $MRK $PFE $TSLA Buying IBRX under $10, feels like when I bought Apple in 2007 when the iPhone just came out. Anktiva and bladder cancer are just the beginning of a new paradigm in cancer treatment
1 · Reply
DailyAnalysis
DailyAnalysis Feb. 18 at 7:19 PM
$PFE is a grind. 1W trend is steady but 1D STOCH is overbought. 4H CCI shows overextension while 30M RSI suggests a cooling period. Wait for a pullback before getting in. @DailyAnalysis
0 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 18 at 7:17 PM
$PFE weird ass price action today
1 · Reply
jogabonito84
jogabonito84 Feb. 18 at 5:55 PM
$IBRX $ONC $MRK $PFE $TSLA Buying IBRX under $10, feels like when I bought Apple in 2007 when the iPhone just came out. Anktiva and bladder cancer are just the beginning of a new paradigm in cancer treatment
0 · Reply
Latest News on PFE
Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 18 hours ago

Is There 25% Downside For Pfizer Stock?

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Feb 18, 2026, 11:30 AM EST - 18 hours ago

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 5:42 PM EST - 1 day ago

Pfizer: The Rebound Looks Unsustainable

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 1 day ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 6 days ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 6 days ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Pfizer: A Great Opportunity Post Earnings

Feb 11, 2026, 6:08 PM EST - 7 days ago

Pfizer: A Great Opportunity Post Earnings

2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 7 days ago

2 Urgent Sells And 2 No Brainer Dividend Buys

ABBV AEP AMGN BMY ESS HASI HD

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 7 days ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 8 days ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Feb 8, 2026, 10:19 PM EST - 10 days ago

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 12 days ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

Feb 6, 2026, 7:25 AM EST - 12 days ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

ARCC ARLP CNQ EPD EQNR F FINV

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 12 days ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 13 days ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Feb 3, 2026, 3:00 PM EST - 15 days ago

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Pfizer: Messy Q4 Earnings Mask An Improving Business

Feb 3, 2026, 2:02 PM EST - 15 days ago

Pfizer: Messy Q4 Earnings Mask An Improving Business

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 15 days ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 15 days ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Feb 3, 2026, 11:56 AM EST - 15 days ago

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 15 days ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 15 days ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 15 days ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 15 days ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Feb 3, 2026, 7:28 AM EST - 15 days ago

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Feb 3, 2026, 7:21 AM EST - 15 days ago

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Feb 3, 2026, 7:18 AM EST - 15 days ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Feb 3, 2026, 7:02 AM EST - 15 days ago

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Feb 3, 2026, 6:57 AM EST - 15 days ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats fourth-quarter profit estimates on strong drug demand

Feb 3, 2026, 6:50 AM EST - 15 days ago

Pfizer beats fourth-quarter profit estimates on strong drug demand

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Feb 3, 2026, 6:45 AM EST - 15 days ago

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Feb 3, 2026, 6:45 AM EST - 15 days ago

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

Feb 3, 2026, 6:40 AM EST - 15 days ago

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer

Feb 2, 2026, 8:42 AM EST - 16 days ago

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer

SNY

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Feb 2, 2026, 1:01 AM EST - 17 days ago

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill

Jan 31, 2026, 3:47 AM EST - 19 days ago

5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill

BBY CAG EQR FRT KEY LYB MAA

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Jan 30, 2026, 10:31 AM EST - 19 days ago

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Why Dividend Stocks Are Essential For What Comes Next

Jan 30, 2026, 7:30 AM EST - 19 days ago

Why Dividend Stocks Are Essential For What Comes Next

AM CAG EPD ET KMI LLY MPLX

Pfizer: A High-Yield Pharma At A Turning Point

Jan 29, 2026, 9:00 AM EST - 20 days ago

Pfizer: A High-Yield Pharma At A Turning Point

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

Jan 27, 2026, 4:52 PM EST - 22 days ago

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

ABBV LLY

Pfizer vs. Merck Stock And JNJ

Jan 27, 2026, 7:40 AM EST - 22 days ago

Pfizer vs. Merck Stock And JNJ

Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance

Jan 27, 2026, 6:02 AM EST - 23 days ago

Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance

Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)

Jan 23, 2026, 10:33 AM EST - 26 days ago

Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)

December Readers ID'd 9 Ideal 'Safer' Dividends In 40 Dogs

Jan 23, 2026, 9:54 AM EST - 26 days ago

December Readers ID'd 9 Ideal 'Safer' Dividends In 40 Dogs

AGNC AGNCP ARLP ECC EFC ET FBRT

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Jan 20, 2026, 12:34 PM EST - 4 weeks ago

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

Jan 20, 2026, 12:18 PM EST - 4 weeks ago

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

NVO

Novavax enters license agreement with Pfizer for vaccine development

Jan 20, 2026, 7:11 AM EST - 4 weeks ago

Novavax enters license agreement with Pfizer for vaccine development

NVAX

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Jan 20, 2026, 2:19 AM EST - 4 weeks ago

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

Jan 19, 2026, 8:10 PM EST - 4 weeks ago

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

BDX DD MSFT ORCL PH Q SLB

MoneyShow's Best Investment Ideas For 2026: Part 7

Jan 19, 2026, 2:20 PM EST - 4 weeks ago

MoneyShow's Best Investment Ideas For 2026: Part 7

PLD PLG PM QUIK RCAT

DragonAlgo
DragonAlgo Feb. 19 at 2:22 AM
🐉 $PFE PUT — DragonAlgo® Signal Contract: PFE PUT Expiry: 2026-02-20 | Strike: $27.00 | Type: PUT Option Plan (premium): Entry: $0.10 Stop: $0.07 TP1: $0.12 TP2: $0.16 TP3: $0.23 🔗 https://dragonalgo.com
0 · Reply
Charterdi3
Charterdi3 Feb. 19 at 12:53 AM
$HR $UNH $PFE End of week watch !!!!
0 · Reply
Outcomes
Outcomes Feb. 18 at 11:23 PM
$MRNA $PFE ….mRNA bad
0 · Reply
F_I_R_E_
F_I_R_E_ Feb. 18 at 9:25 PM
$WMT stop crying about the p/e. Plenty of stocks with p/e under 30 ex: $T $PFE $LYFT , but look at their performance 🎭
2 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 18 at 9:01 PM
$PFE shitter lol
0 · Reply
himsssss
himsssss Feb. 18 at 8:49 PM
$VKTX $PFE $NVO$ABBV The management team added each other on myspace this time. Trust me bros.
0 · Reply
jogabonito84
jogabonito84 Feb. 18 at 8:13 PM
$IBRX $ONC $MRK $PFE $TSLA Buying IBRX under $10, feels like when I bought Apple in 2007 when the iPhone just came out. Anktiva and bladder cancer are just the beginning of a new paradigm in cancer treatment
1 · Reply
DailyAnalysis
DailyAnalysis Feb. 18 at 7:19 PM
$PFE is a grind. 1W trend is steady but 1D STOCH is overbought. 4H CCI shows overextension while 30M RSI suggests a cooling period. Wait for a pullback before getting in. @DailyAnalysis
0 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 18 at 7:17 PM
$PFE weird ass price action today
1 · Reply
jogabonito84
jogabonito84 Feb. 18 at 5:55 PM
$IBRX $ONC $MRK $PFE $TSLA Buying IBRX under $10, feels like when I bought Apple in 2007 when the iPhone just came out. Anktiva and bladder cancer are just the beginning of a new paradigm in cancer treatment
0 · Reply
Sunny3999
Sunny3999 Feb. 18 at 5:11 PM
$PMN NEXT STOP $50 $JNJ $LLY $PFE $REGN
0 · Reply
reyofhope
reyofhope Feb. 18 at 5:04 PM
$PFE when do we moon? When do I get my dividend?
0 · Reply
WuTangClam
WuTangClam Feb. 18 at 5:00 PM
$PFE I have such a big poison at 24$ I bought few puts to hedge 2 months out .. can't believe it's actually holding lol
0 · Reply
SeriouslyWhy
SeriouslyWhy Feb. 18 at 4:46 PM
$PFE
0 · Reply
taxplanr
taxplanr Feb. 18 at 4:34 PM
Will it replace $MRK Keytruda? As well as the amplified side effects from malignantRNA from $MRNA $BNTX $BMY $PFE
0 · Reply
Pf89
Pf89 Feb. 18 at 4:16 PM
$PFE a lovely day
0 · Reply
umiak1
umiak1 Feb. 18 at 3:57 PM
$PFE “Pfizer Inc's peer group average for short interest as a percentage of float is 3.59%, which means the company has less short interest than most of its peers.”
0 · Reply
tradesaur
tradesaur Feb. 18 at 3:46 PM
$PFE
2 · Reply
Quantumup
Quantumup Feb. 18 at 2:54 PM
Cantor reiterated Top Pick $IDYA at an Overweight rating heading into Ideaya's topline PFS readout from the Ph2/3 OptimUM-02 trial in 1L MUM (metastatic uveal melanoma) slated for the last week of March. $IMCR $REPL $BMY $PFE GILD AMGN GSK MRK DCTH Here's what Cantor said in its note to investors: https://x.com/Quantumup1/status/2024134420320374998?s=20
0 · Reply
TeresaTrades
TeresaTrades Feb. 18 at 2:50 PM
Largest CALL OI decreases $TSM $NVDA $PFE $WYNN $COP
0 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 18 at 2:49 PM
$PFE lol
0 · Reply
frogman2000
frogman2000 Feb. 18 at 1:29 PM
$PFE MM don’t want the cat to get out of the bag on CRDF and what is happening with the focus on Folfiri. With BRAF they are seeing an incredible opportunity to build a platform around Folfiri and CRDF is central to this platform. PFE will not wait to acquire the Onvansertib capability either directly or through some sort of strategic licensing deal. Congrats Longs. Short availability is drying up and we are close to an announcement.
0 · Reply